 |
인쇄하기
취소
|
Choong-wae wins US patent for Wnt target anticancer agent
Choong-wae Pharm said on September 18 it recently won the U.S. substance patent for the building-block molecules of Wnt target anticancer drug (code name: CWP231A).
“We have a plan to explore overseas markets for with licensing-out strategies,” said a senior company official.
The firm is now undertaking preclinical studies on CWP231A in Canada with a plan to launch it in 2014 after succes...
“We have a plan to explore overseas markets for with licensing-out strategies,” said a senior company official.
The firm is now undertaking preclinical studies on CWP231A in Canada with a plan to launch it in 2014 after succes...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.